Examines whether corporations should be allowed to patent life forms or parts thereof.
This paper focuses on the manner in which the current business environment is impacting the development and introduction of genetically modified organisms (GMOs).
The paper demonstrates that the free market or capitalist model is not ethically the most appropriate method of developing and introducing GMOs.
The paper demonstrates that the free market or capitalist model is not ethically the most appropriate method of developing and introducing GMOs.